These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10750985)

  • 41. [Quantitative salivary gland scintigraphy--a recommended examination prior to and after radioiodine therapy].
    Bohuslavizki KH; Brenner W; Lassmann S; Tinnemeyer S; Kalina S; Clausen M; Henze E
    Nuklearmedizin; 1997 Apr; 36(3):103-9. PubMed ID: 9162904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unusual radioiodine uptake caused by metallic sutures in the skull in a patient with thyroid cancer.
    Modoni S; Martino G; Guerra M; Frusciante V
    Clin Nucl Med; 2000 Dec; 25(12):1053-4. PubMed ID: 11129153
    [No Abstract]   [Full Text] [Related]  

  • 43. Exercise-induced radio-iodine accumulation in scalp and hair during admission of 131I therapy for thyroid cancer.
    Zakavi SR; Kakhki VD
    Thyroid; 2006 Nov; 16(11):1185-6. PubMed ID: 17123349
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of thyroid cancer.
    Blahd WH
    Compr Ther; 1985 Sep; 11(9):26-32. PubMed ID: 4042593
    [No Abstract]   [Full Text] [Related]  

  • 45. Nuclear medicine and thyroid cancer.
    Jana S; Abdel-Dayem HM; Young I
    Eur J Nucl Med; 1999 Dec; 26(12):1528-32. PubMed ID: 10638402
    [No Abstract]   [Full Text] [Related]  

  • 46. Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled study.
    Bohuslavizki KH; Klutmann S; Brenner W; Mester J; Henze E; Clausen M
    J Clin Oncol; 1998 Nov; 16(11):3542-9. PubMed ID: 9817273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Parotid gland function following radioiodine therapy of thyroid cancer based on data from radionuclide sialoscintigraphy].
    Sorokin IN; Prikhod'ko AG
    Stomatologiia (Mosk); 1987; 66(2):50-2. PubMed ID: 3033850
    [No Abstract]   [Full Text] [Related]  

  • 48. Lick your lips: a case of salivary contamination after I-131 therapy for thyroid carcinoma.
    Roman MR; Larcos G; Devadas M
    Clin Nucl Med; 2002 Jun; 27(6):462. PubMed ID: 12045452
    [No Abstract]   [Full Text] [Related]  

  • 49. Salivary gland protection by S-2-(3-aminopropylamino)-ethylphosphorothioic acid (amifostine) in high-dose radioiodine treatment: results obtained in a rabbit animal model and in a double-blind multi-arm trial.
    Bohuslavizki KH; Klutmann S; Jenicke L; Kröger S; Buchert R; Mester J; Clausen M
    Cancer Biother Radiopharm; 1999 Oct; 14(5):337-47. PubMed ID: 10850318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. False-positive "necklace sign" on whole-body thyroid cancer survey--a case report.
    Beaulieu S; Djang D; Minoshima S
    J Nucl Med Technol; 2005 Mar; 33(1):42-3. PubMed ID: 15731020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stunned thyroid after a diagnostic dose of I-131 for a whole body scan.
    Kao CH
    Clin Nucl Med; 1998 Feb; 23(2):102-4. PubMed ID: 9481500
    [No Abstract]   [Full Text] [Related]  

  • 52. I-123 uptake by intrathoracic stomach.
    Sathekge MM; Mokgoro NP; Mpikashe P; Ramafi OE
    Clin Nucl Med; 2005 Jan; 30(1):42. PubMed ID: 15604972
    [No Abstract]   [Full Text] [Related]  

  • 53. Salivary gland dysfunction following radioactive iodine therapy.
    Wiesenfeld D; Webster G; Cameron F; Ferguson MM; MacFadyen EE; MacFarlane TW
    Oral Surg Oral Med Oral Pathol; 1983 Feb; 55(2):138-41. PubMed ID: 6572864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The utility of radioiodine scans prior to iodine 131 ablation in patients with well-differentiated thyroid cancer.
    Van Nostrand D; Aiken M; Atkins F; Moreau S; Garcia C; Acio E; Burman K; Wartofsky L
    Thyroid; 2009 Aug; 19(8):849-55. PubMed ID: 19281428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial.
    Upadhyaya A; Zhou P; Meng Z; Wang P; Zhang G; Jia Q; Tan J; Li X; Hu T; Liu N; Wang S; Liu X; Wang H; Zhang C; Zhao F; Yan Z; Wang X; Zhang X; Zhang W
    Nucl Med Commun; 2017 Nov; 38(11):891-903. PubMed ID: 28806348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Salivary gland accumulation of meta-[131I]iodobenzylguanidine.
    Nakajo M; Shapiro B; Sisson JC; Swanson DP; Beierwaltes WH
    J Nucl Med; 1984 Jan; 25(1):2-6. PubMed ID: 6726418
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
    Gerard SK; Dam HQ
    Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
    [No Abstract]   [Full Text] [Related]  

  • 58. Dramatic parotid uptake of I-131 on a diagnostic whole-body scan.
    Carlisle MR; McDougall IR
    Clin Nucl Med; 2000 Nov; 25(11):895-7. PubMed ID: 11079586
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-thyroglobulin antibodies and risk of finding iodine avid metastases on post-radioactive iodine ablation scan in low-risk thyroid cancer patients.
    Rosario PW
    J Endocrinol Invest; 2017 Sep; 40(9):1023. PubMed ID: 28569364
    [No Abstract]   [Full Text] [Related]  

  • 60. [Importance of scintigraphy in the evaluation of surgical treatment outcome in differentiated cancer of the thyroid gland].
    Protsyk VS; Shishkina VV; Chebotareva ED; Siniuta BF; Dzhuzha DA; Sagan DL
    Klin Khir; 1997; (9-10):29-32. PubMed ID: 9511322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.